SCHEMBL5242452

SCHEMBL5242452

Fc1ccc2c(c1I)CN(Cc1ccc(OC(F)(F)F)cc1)C2

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.51
TSHR P16473 1/20 0.48
TNF P01375 1/20 0.41
NOD2 Q9HC29 1/20 0.41
NOD1 Q9Y239 1/20 0.41
BCHE P06276 2/20 0.40
ACHE P22303 2/20 0.40
BACE1 P56817 2/20 0.40
KCNH2 Q12809 2/20 0.39
ACACB O00763 1/20 0.39
TEAD1 P28347 3/20 0.38
LMNA P02545 1/20 0.38
HTR2C P28335 1/20 0.38
GNRHR P30968 1/20 0.37
DRD4 P21917 3/20 0.37
DRD2 P14416 2/20 0.37
DRD3 P35462 2/20 0.37
HCRTR1 O43613 2/20 0.37
HCRTR2 O43614 2/20 0.37
LSS P48449 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29710313 0.85 SIGMAR1 (0.44) ALDH1A1LMNAHTR2CDRD4DRD2
SCHEMBL19357722 0.85 SIGMAR1 (0.44) ALDH1A1LMNAHTR2CDRD4DRD2
SCHEMBL5240721 0.79 ALDH1A1 (0.50) ALDH1A1TSHRTNFNOD2NOD1
SCHEMBL5243815 0.76 ALDH1A1 (0.52) ALDH1A1TSHRTNFNOD2NOD1
SCHEMBL2019631 0.75 GRM2 (0.42) ALDH1A1TSHRHCRTR1HCRTR2
SCHEMBL5240643 0.74 ALDH1A1 (0.50) ALDH1A1TSHRTNFNOD2NOD1
SCHEMBL5239908 0.73 ALDH1A1 (0.52) ALDH1A1TSHRTNFNOD2NOD1
SCHEMBL2056301 0.73 ALDH1A1 (0.58) ALDH1A1TSHRTNFNOD2NOD1
SCHEMBL5242288 0.71 ALDH1A1 (0.44) ALDH1A1TSHRTNFNOD2NOD1
SCHEMBL5241430 0.71 ALDH1A1 (0.52) ALDH1A1TSHRTNFNOD2NOD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1778634-A1 ISOINDOLONE COMPOUNDS AND THEIR USE AS METABOTROPIC GLUTAMATE RECEPTOR POTENTIATORS AstraZeneca AB (SE) 2007-05-02 EP disclosed
WO-2006020879-A1 ISOINDOLONE COMPOUNDS AND THEIR USE AS METABOTROPIC GLUTAMATE RECEPTOR POTENTIATORS ASTRAZENECA AB (SE) 2006-02-23 WO disclosed